67
Participants
Start Date
March 2, 2024
Primary Completion Date
July 29, 2025
Study Completion Date
July 29, 2025
remifentanil of the assigned dose
Ambu Auragain will be inserted after general anesthesia is induced with remimazolam and remifentanil. Each patient will be assigned with a certain dose of remifentanil, according to whether the previous patient's LMA insertion process was successful or not.
Ambu Auragain for airway management
Ambu Auragain, a type of laryngeal mask airway, will be inserted into every patient after general anesthesia has been induced.
RECRUITING
Severance Hospital, Seoul
Yonsei University
OTHER